BP000140-C021: Recombinant Human Interleukin-17A (IL-17A) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent induction of IL-6 in primary human foreskin fibroblasts was found to be approximately 2 ug/ml, corresponding to a Specific Activity of 5 x 105 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000139-CYT-623: Recombinant Human IL-17 A/F Heterodimer
Source: E. coli-derived.
Purity > 98%, by SDS-PAGE.BP000139-CYT-640: Recombinant Mouse IL-17 A/F Heterodimer
Source: E. coli-derived.
Purity > 97%, by SDS-PAGE.BP000139-CYT-677: Recombinant Rat IL-17 A/F Heterodimer
Source: E. coli-derived.
Purity > 97%, by SDS-PAGE.BP000140-CYT-102: Recombinant Human Interleukin-17A (IL-17A), HEK Protein
Source: HEK-derived.
The specific activity was determined by the dose-dependent induction of IL-6 secretion from NDHF Adult fibroblasts and is typically 5-25 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000140-CYT-250: Recombinant Human Interleukin-17A (IL-17A) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent induction of IL-6 in Hs68 cell line was found to be approximately 2 ug/ml corresponding to a Specific Activity of 500,000 IU/mg.
Purity: > 95% by SDS-PAGE.